Shares of Universal Health Services, Inc. (NYSE:UHS – Get Free Report) have earned an average recommendation of “Moderate Buy” from the fifteen analysts that are covering the company, MarketBeat reports. Five analysts have rated the stock with a hold recommendation, nine have issued a buy recommendation and one has issued a strong buy recommendation on the company. The average 12-month price target among brokers that have covered the stock in the last year is $231.00.
A number of analysts have recently weighed in on UHS shares. TD Cowen cut their price objective on shares of Universal Health Services from $283.00 to $275.00 and set a “buy” rating on the stock in a research note on Monday. Stephens reiterated an “equal weight” rating and issued a $200.00 target price on shares of Universal Health Services in a research report on Thursday, July 25th. Robert W. Baird boosted their price objective on Universal Health Services from $236.00 to $274.00 and gave the stock an “outperform” rating in a research note on Wednesday, September 4th. StockNews.com raised shares of Universal Health Services from a “buy” rating to a “strong-buy” rating in a research note on Saturday, October 19th. Finally, Barclays boosted their price objective on shares of Universal Health Services from $256.00 to $271.00 and gave the company an “overweight” rating in a report on Friday, October 25th.
Read Our Latest Stock Report on UHS
Universal Health Services Stock Performance
Universal Health Services (NYSE:UHS – Get Free Report) last released its quarterly earnings results on Thursday, October 24th. The health services provider reported $3.71 EPS for the quarter, missing analysts’ consensus estimates of $3.75 by ($0.04). Universal Health Services had a net margin of 6.66% and a return on equity of 15.75%. The business had revenue of $3.96 billion during the quarter, compared to analysts’ expectations of $3.90 billion. During the same quarter last year, the business posted $2.55 earnings per share. The company’s quarterly revenue was up 11.3% compared to the same quarter last year. Research analysts expect that Universal Health Services will post 15.9 EPS for the current fiscal year.
Universal Health Services announced that its board has authorized a stock buyback plan on Wednesday, July 24th that permits the company to repurchase $1.00 billion in shares. This repurchase authorization permits the health services provider to repurchase up to 8% of its shares through open market purchases. Shares repurchase plans are often a sign that the company’s board believes its shares are undervalued.
Insiders Place Their Bets
In other Universal Health Services news, Director Warren J. Nimetz sold 3,444 shares of Universal Health Services stock in a transaction that occurred on Monday, August 12th. The stock was sold at an average price of $217.64, for a total value of $749,552.16. Following the transaction, the director now directly owns 3,971 shares in the company, valued at approximately $864,248.44. This trade represents a 0.00 % decrease in their position. The sale was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. In related news, Director Warren J. Nimetz sold 3,444 shares of the firm’s stock in a transaction dated Monday, August 12th. The shares were sold at an average price of $217.64, for a total value of $749,552.16. Following the completion of the sale, the director now owns 3,971 shares in the company, valued at $864,248.44. This trade represents a 0.00 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. Also, Director Nina Chen-Langenmayr sold 850 shares of the business’s stock in a transaction that occurred on Wednesday, August 7th. The stock was sold at an average price of $212.11, for a total value of $180,293.50. Following the transaction, the director now owns 1,985 shares in the company, valued at $421,038.35. The trade was a 0.00 % decrease in their position. The disclosure for this sale can be found here. 16.10% of the stock is currently owned by insiders.
Institutional Investors Weigh In On Universal Health Services
Several institutional investors have recently made changes to their positions in UHS. Point72 Asset Management L.P. grew its holdings in Universal Health Services by 362.3% in the second quarter. Point72 Asset Management L.P. now owns 322,626 shares of the health services provider’s stock valued at $59,663,000 after purchasing an additional 252,846 shares during the last quarter. Marshall Wace LLP lifted its holdings in shares of Universal Health Services by 357.9% in the second quarter. Marshall Wace LLP now owns 261,221 shares of the health services provider’s stock valued at $48,308,000 after purchasing an additional 204,178 shares in the last quarter. Lazard Asset Management LLC grew its position in shares of Universal Health Services by 1,191.8% in the first quarter. Lazard Asset Management LLC now owns 215,215 shares of the health services provider’s stock valued at $39,267,000 after purchasing an additional 198,555 shares during the last quarter. Lord Abbett & CO. LLC purchased a new position in shares of Universal Health Services during the 1st quarter worth approximately $25,032,000. Finally, Pzena Investment Management LLC lifted its stake in Universal Health Services by 41.2% in the 1st quarter. Pzena Investment Management LLC now owns 455,773 shares of the health services provider’s stock valued at $83,160,000 after buying an additional 132,942 shares in the last quarter. 86.05% of the stock is currently owned by hedge funds and other institutional investors.
Universal Health Services Company Profile
Universal Health Services, Inc, through its subsidiaries, owns and operates acute care hospitals, and outpatient and behavioral health care facilities. It operates through Acute Care Hospital Services and Behavioral Health Care Services segments. The company's hospitals offer general and specialty surgery, internal medicine, obstetrics, emergency room care, radiology, oncology, diagnostic and coronary care, pediatric services, pharmacy services, and/or behavioral health services.
Read More
- Five stocks we like better than Universal Health Services
- What Investors Must Know About Over-the-Counter (OTC) Stocks
- Boeing: Why Analysts Think Now’s The Time To Be Brave
- Insider Trades May Not Tell You What You Think
- Advanced Micro Devices is Building Momentum with AI: Buy the Dip
- Why Are Stock Sectors Important to Successful Investing?
- Can Evolv Stock Recover From Its Massive Self-Inflicted Drop?
Receive News & Ratings for Universal Health Services Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Universal Health Services and related companies with MarketBeat.com's FREE daily email newsletter.